NIPPON CHEMIPHAR CO., LTD.

4539・Standard Market・Pharmaceuticals

Official website

NIPPON CHEMIPHAR CO., LTD.

4539・Standard Market・Pharmaceuticals

Official website

NIPPON CHEMIPHAR CO., LTD.4539

Reference Indicators

Market Cap

70¥100M

P/E (Forecast)

98.3x

P/B

0.3x

Dividend Yield (Forecast)

3.06%

ROE

1.0%

EV/EBITDA

9.8x

Financial Summary

Unit: ¥M

Item	2022Mar 2022	2023Mar 2023	2024Mar 2024	2025Mar 2025	2026Mar 2026
Net Sales	32,506	31,559	30,748	32,570	33,090
Cost of Sales	23,432	23,374	23,010	23,824	24,693
Gross Profit	9,073	8,184	7,737	8,746	8,397
SG&A Expenses	8,248	8,425	8,232	8,139	8,217
Operating Income	825	-241	-494	606	179
Non-operating Income	449	475	449	106	310
Non-operating Expenses	251	175	174	269	262
Ordinary Income	1,022	58	-219	443	227
Extraordinary Income	141	422	17	153	157
Extraordinary Losses	187	—	—	342	163
Pre-tax Income	976	480	-202	253	221
Income Taxes	275	141	-21	-41	23
Net Income	700	339	-180	294	198
EBITDA	2,411	1,259	965	1,983	1,738
Gross Margin	27.9%	25.9%	25.2%	26.9%	25.4%
Operating Margin	2.5%	-0.8%	-1.6%	1.9%	0.5%
ROA	1.4%	0.7%	-0.4%	0.6%	0.4%
ROE	3.8%	1.8%	-1.0%	1.6%	1.0%

Segment Performance

Unit: ¥M

2026

Segment	Net Sales	Operating Income	Operating Margin
医薬品事業	31,868	187	0.6%
その他	1,222	-7	-0.6%